Journal of Neurology

, Volume 239, Issue 5, pp 284–286 | Cite as

The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients

  • J. Bauer
  • L. Wild
  • D. Flügel
  • H. Stefan
Original Communications
  • 62 Downloads

Summary

Ten female patients suffering from catamenial epilepsy were treated with a synthetic analogue of the gonadotrophin releasing hormone (GnRH) in additon to antiepileptic drugs. Three of the patients became seizure free, in four patients seizure frequency decreased and in one patient seizures were of shorter duration. In only two of the patients was there no therapeutic effect. Adverse effects, including hot flushes, headache and increase in weight, were noticed in eight patients. These results support the hypothesis that treatment with a synthetic GnRH analogue might be helpful in patients with intractable catamenial epilepsies.

Key words

Catamenial epilepsy Seizure clustering Intractable epilepsy Gonadotrophin releasing hormone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Almquist R (1955) The rhythm of epileptic attacks and its relationship to the menstrual cycle. Munksgaard, KopenhagenGoogle Scholar
  2. 2.
    Ansell B, Clarke E (1956) Epilepsy and menstruation, the role of water retention. Lancet II:1232–1235Google Scholar
  3. 3.
    Böckström T, Landren S, Zetterlund B, Blom S, Dubrovsky B, Bixo M, Södergard R (1984) Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure variation during the menstrual cycle. In: Porter R (ed) Advances in epileptology. Raven Press, New York, pp 269–277Google Scholar
  4. 4.
    Bonuccelli U, Melis GB, Paoletti AM (1989) Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res 3:100–106Google Scholar
  5. 5.
    Comite F, Jensen P (1988) Bone density changes associated with GnRH analogues. Gynecol Endocrinol 2 [Suppl 1]:105Google Scholar
  6. 6.
    Coy DH, LaBrie F, Savary M (1975) LH-releasing activity of potent LH-RH analogs in vitro. Biochem Biophys Res Commun 67:576–679Google Scholar
  7. 7.
    Feely M, Gibson J (1984) Intermittent clobazam for catamenial epilepsy. J Neurol Neurosurg Psychiatry 47:1279–1282Google Scholar
  8. 8.
    Fraser HM, Lincoln GA (1980) Effects of chronic treatment with an LHRH agonist on the secretion of LH, FSH and testosterone in the ram. Biol Reprod 22:269–276Google Scholar
  9. 9.
    Gowers BR (1885) Epilepsy and other chronic convulsive diseases — their causes, symptoms, and treatment. Williamwood, New YorkGoogle Scholar
  10. 10.
    Herzog AG (1986) Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorderes. Neurology 36:1607–1610Google Scholar
  11. 11.
    Herzog AG (1988) Clomiphene therapy in epileptic women with menstrual disorders. Neurology 38:432–434Google Scholar
  12. 12.
    Jacono JJ, Robertson JM (1987) The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia 28:571–577Google Scholar
  13. 13.
    Kumar N, Behari M, Ahuja GK, Jailkhani BL (1988) Phenytoin levels in catamenial epilepsy. Epilepsia 29:155–158Google Scholar
  14. 14.
    Livingston S (1972) Comprehensive management of epilepsy in infancy, childhood and adolescence. Thomas, Springfield, Ill, pp 101–102Google Scholar
  15. 15.
    Mason-Garcia M, Vigh S, Comaru-Schally AM (1985) Radioimmunoassay for 6-n-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum level after administration of long-acting microcapsule formulations. Proc Natl Acad Sci USA 82:1547–1550Google Scholar
  16. 16.
    Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC (1984) Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 34:1255–1258Google Scholar
  17. 17.
    Milton JG, Gotman J, Remillard GM, Andermann F (1987) Timing of seizure recurrence in adult epileptic patients: a statistical analysis. Epilepsia 28:471–478Google Scholar
  18. 18.
    Murri L, Bonuccelli U, Melis GB (1986) Neuroendocrine evaluation in catamenial epilepsy. Funct Neurol 1:399–403Google Scholar
  19. 19.
    Newmark ME, Penry JK (1980) Catamenial epilepsy: a review. Epilepsia 21:281–300Google Scholar
  20. 20.
    Rosciszewska D, Buntner B, Guz I, Zawisza L (1986) Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry 49:47–51Google Scholar
  21. 21.
    Rubinow DR, Schmidt PJ (1989) Menstrual and formal mood disorders. In: Demers LM, McGuire JL, Phillips A, Rubinow DR (eds) Premenstrual, postpartum, and menopausal mood disorders. Urban & Schwarzenberg, Baltimore Munich, pp 35–51Google Scholar
  22. 22.
    Schally AV, Airmura A, Baba Y (1971) Isolation and properties of the FSH and LH releasing hormone. Biochem Biophys Res Commun 43:393–398Google Scholar
  23. 23.
    Schmidt D (1981) Effect of antiepileptic drugs on estrogen and progesterone metabolism and on oral contraception. In: Dam M, Gram L, Penry JK (eds) Advances in epileptology: XIIth Epilepsy International Symposium. Raven Press, New York, pp 423–431Google Scholar
  24. 24.
    Shavit G, Lerman P, Korczyn A, Kivity S, Bechar M, Gitter S (1984) Phenytoin pharmacokinetics in catamenial epilepsy. Neurology 34:959–961Google Scholar
  25. 25.
    Waibel-Treber S, Minne HW, Scharla SH (1989) Reversible bone loss in women treated with GnRH agonists for endometriosis and uterine leiomyomya. Hum Reprod 4:384–388Google Scholar
  26. 26.
    Wildt L, Sir-Petermann T (1989) Physiologic und Pathophysiologie der Ovarialfunktion. Kliniksarzt 18:503–510Google Scholar
  27. 27.
    Zorn JR, Soubrane O, Siboni O (1987) Medical reversible castration withd-Trp-6-LHRH microcapsules for the treatment of endometriosis. Contrib Gynecol Obst 16:254–259Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • J. Bauer
    • 1
  • L. Wild
    • 2
  • D. Flügel
    • 1
  • H. Stefan
    • 1
  1. 1.Neurologische Klinik der Universität Erlangen-NürnbergErlangenGermany
  2. 2.Frauenklinik der Universität Erlangen-NürnbergErlangenGermany

Personalised recommendations